Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial

Benutzer: Gast

Titel:: Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Eichhorn, Florian; Klotz, Laura V.; Bischoff, Helge; Thomas, Michael; Lasitschka, Felix; Winter, Hauke; Hoffmann, Hans; Eichhorn, Martin E.
Zeitschriftentitel:: BMC Cancer
Jahr:: 2019
Band / Volume:: 19
Heft / Issue:: 1
Volltext / DOI:: doi:10.1186/s12885-019-5624-2
Verlag / Institution:: Springer Science and Business Media LLC
E-ISSN:: 1471-2407
Publikationsdatum:: 02.05.2019
BibTeX

Vorkommen: